-+ 0.00%
-+ 0.00%
-+ 0.00%

Shenlian Biotech announced that Yangzhou Shizhiyuan Biotechnology Co., Ltd., a subsidiary of the company, recently obtained an invention patent for “treatment and functional cure of HIV infection mediated by monoclonal antibodies against CD4 mediating suppression of competitive HIV” from the State Intellectual Property Office. The invention patent relates to CD4 monoclonal antibodies, their compositions, and methods of using this composition to prevent, treat and functionally cure HIV infection.

Zhitongcaijing·12/19/2025 13:33:21
Listen to the news
Shenlian Biotech announced that Yangzhou Shizhiyuan Biotechnology Co., Ltd., a subsidiary of the company, recently obtained an invention patent for “treatment and functional cure of HIV infection mediated by monoclonal antibodies against CD4 mediating suppression of competitive HIV” from the State Intellectual Property Office. The invention patent relates to CD4 monoclonal antibodies, their compositions, and methods of using this composition to prevent, treat and functionally cure HIV infection.